Great leaders never fixate on a single result or metric. Instead of bottom-line thinking, they set a contagious long-term ...
The Goldman Sachs Conviction List is a curated list of stocks that the firm’s research team believes are highly likely to outperform the market. It’s a tool for investors to identify stocks with ...
Fifteen years later, Rob has rebuilt his super with a concentrated ASX portfolio, strict discipline and a value investing approach.
ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
CSL chief financial officer Ken Lim says the global healthcare giant is trying to simplify its organisation after conceding that a slowdown in its ability to make quick decisions had hurt its ...
A major new clinical trial for an mRNA bird flu vaccine is set to begin in Britain in the coming weeks, it was announced on ...
CSL’s fireman tells us how he’s reviving the Australian market’s Bambi. Investors are yet to reward him for it. One of the surprising things about CSL’s earnings season shocker was that it reaffirmed ...
Carlisle United have announced season ticket details for the 2026/27 campaign – having frozen prices for another season.
Carlisle United could be a step closer to knowing their likely play-off opponents tonight. The Blues, in the National League ...